Carillon Tower Advisers’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$19.5M Sell
60,160
-3,040
-5% -$841K 0.12% 244
2020
Q3
$17.5M Sell
63,200
-27,027
-30% -$7.79M 0.23% 161
2020
Q2
$21.8M Buy
+90,227
New +$18.1M 0.17% 183
2019
Q4
Sell
-113,675
Closed -$20.2M 490
2019
Q3
$20.2M Sell
113,675
-194,817
-63% -$42.1M 0.14% 246
2019
Q2
$80.4M Buy
308,492
+91,218
+42% +$24.2M 0.55% 41
2019
Q1
$62M Buy
217,274
+41,589
+24% +$13.8M 0.44% 66
2018
Q4
$57.1M Sell
175,685
-132,319
-43% -$46M 0.48% 52
2018
Q3
$135M Sell
308,004
-92,344
-23% -$36.4M 0.96% 3
2018
Q2
$164M Buy
400,348
+174,198
+77% +$63.1M 1.29% 2
2018
Q1
$110M Buy
226,150
+68,574
+44% +$17.4M 0.86% 17
2017
Q4
$29.5K Buy
+157,576
New +$29.4M 0.31% 116

Other funds holding ABMD